MAPK Pathway-Activating Alteration and Immunotherapy Efficacy in Squamous Cell Lung Carcinoma: Results from the Randomized, Prospective SQUINT Trial. - Cappuzzo F; Ricciuti B; Delmonte A; Bonanno L; Wang X; Lye WK; Görtz A; Andrikou K; Dal Maso A; Minuti G; Papi M; Alessi JV; et al. (Clinical cancer research : an official journal of the American Association for Cancer Research, 2025)